CDEK
← All drugs Report issue

rivipansel

Small moleculeexperimental

Clinical trial activity

9 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started May 1, 2009 (NCT00911495)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O
Mol. weight
1447.44 g/mol
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • gmi-1070
  • gmi-1070
  • gmi-1070
  • pf-06460031
  • pf-06460031
  • pf-0646003102
  • pf-0646003102
  • rivipansel
  • rivipansel
  • rivipansel
  • rivipansel
  • rivipansel sodium
  • rivipansel sodium

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02998099Phase 1Jan 26, 2017Pfizer
NCT02871570Phase 1Sep 21, 2016Pfizer
NCT02813798Phase 1Jun 24, 2016Pfizer
NCT02433158Phase 3Dec 16, 2015Pfizer
NCT02217917Phase 1Oct 1, 2015Pfizer
NCT02187003Phase 3Jun 8, 2015Pfizer
NCT01941511Phase 1Aug 1, 2013Pfizer
NCT01119833Phase 2May 1, 2010Duke University, GlycoMimetics, Inc., Pfizer
NCT00911495Phase 1/Phase 2 (Phase 2)May 1, 2009GlycoMimetics, Inc., Pfizer
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
PfizerFor profit9932009
GlycoMimetics, Inc.For profit2012009
Duke UniversityAcademic/Hospital1012010
3 organizations
Page 1 / 1